Amylases, nucleic acids encoding them and methods for making and using them

Details for Australian Patent Application No. 2004229313 (hide)

Owner Verenium Corporation

Inventors Frey, Gerhard; Miller, Carl; Barton, Nelson; Gray, Kevin; Callen, Walter; Richardson, Toby; O'Donoghue, Eileen; Slupska, Matgorzata; Kerovuo, Janne S.

Agent Freehills

Pub. Number AU-B-2004229313

PCT Pub. Number WO2004/091544

Priority 60/459,014 28.03.03 US; 10/385,305 06.03.03 US

Filing date 8 March 2004

Wipo publication date 28 October 2004

Acceptance publication date 19 August 2010

International Classifications

C12N 9/26 (2006.01) Enzymes, e.g. ligases (6.) - acting on alpha-1, 4-glucosidic bonds, e.g. hyaluronidase, invertase, amylase

C12N 1/15 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/21 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 9/28 (2006.01) Enzymes, e.g. ligases (6.)

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

C12N 15/56 (2006.01) Mutation or genetic engineering - acting on glycosyl compounds (3.2), e.g. amylase, galactosidase, lysozyme

C12N 15/63 (2006.01) Mutation or genetic engineering - Introduction of foreign genetic material using vectors

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

Event Publications

29 September 2005 PCT application entered the National Phase

  PCT publication WO2004/091544 Priority application(s): WO2004/091544

20 September 2007 Change of Name(s) of Applicant(s), Section 104

  Diversa Corporation The name of the applicant has been changed to Verenium Corporation

19 August 2010 Application Accepted

  Published as AU-B-2004229313

16 December 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004229314-Expandable stent

2004229311-Method of treating autoimmune disease by inducing antigen presentation by tolerance inducing antigen presenting cells